- Report
- March 2023
- 88 Pages
Africa, Middle East
From €1365EUR$1,500USD£1,170GBP
- Report
- March 2023
- 88 Pages
Europe
From €1365EUR$1,500USD£1,170GBP
- Report
- March 2023
- 78 Pages
North America
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2022
- 86 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Drug Pipelines
- August 2020
- 123 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Report
- August 2022
Global
From €719EUR$790USD£616GBP
- Report
- August 2022
Global
From €719EUR$790USD£616GBP
- Report
- July 2023
- 321 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- October 2023
- 105 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- April 2023
- 107 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- October 2022
- 42 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Report
- January 2025
- 132 Pages
Global
From €865EUR$950USD£741GBP
- Report
- November 2021
- 620 Pages
Global
From €3640EUR$4,000USD£3,121GBP
- Report
- February 2023
- 349 Pages
Global
From €3249EUR$3,570USD£2,785GBP

The Herpes Drug market is a subset of the Infectious Diseases Drugs market, which includes drugs used to treat a variety of infectious diseases. Herpes drugs are used to treat the herpes simplex virus (HSV) and its associated conditions, such as genital herpes, cold sores, and shingles. These drugs can be administered orally, topically, or intravenously, depending on the severity of the infection. Commonly prescribed herpes drugs include acyclovir, valacyclovir, and famciclovir.
Herpes drugs are typically prescribed for short-term use, as the virus is incurable. However, these drugs can help reduce the severity and duration of symptoms, as well as reduce the risk of transmission. As such, they are an important part of managing the virus.
Some companies in the Herpes Drug market include GlaxoSmithKline, Merck, Pfizer, and Novartis. These companies produce a variety of herpes drugs, including acyclovir, valacyclovir, and famciclovir. Show Less Read more